Posted 17 April, 2023
CytoMed Therapeutics Ltd IPO completed
IPO completed detected for ticker Nasdaq:GDTC in a 424B4 filed on 17 April, 2023.
This is the initial public offering of ordinary shares of CytoMed Therapeutics Limited.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of CytoMed Therapeutics Ltd
Health Care/Life Sciences • Biotechnology
CytoMed Therapeutics Ltd. operates as a biopharmaceutical company. It engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.Market Cap
$25.8M
View Company Details
$25.8M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.